The natural course of untreated neoplasia in barrett’s esophagus – a case-series

E.P.D. Verheij,S.N. van Munster, C.C. Cotton,B.L.A.M. Weusten,L. Alvarez Herrero,A. Alkhalaf,B.E. Schenk,E.J. Schoon,W. Curvers,A.D. Koch,P.J.F. de Jonge, T.J. Tang,W.B. Nagengast, J. Westerhof,M.H.M.G. Houben,N.J. Shaheen,J.J.G.H.M. Bergman,R.E. Pouw

Endoscopy（2022）

引用 0|浏览2

暂无评分

摘要

Aims Endoscopic therapy(ET) is initiated for Barrett’s Esophagus with HGD to prevent non-curable esophageal adenocarcinoma (EAC). Risk estimates for progression to clinically evident EAC are crucial for rational use of ET. We aimed to evaluate time between HGD-diagnosis in BE and development of clinically evident EAC.

查看译文

关键词

esophagus,untreated neoplasia,case-series

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要